DE1598945C3 - Verfahren zur Bestimmung von Proteinen und Polypeptiden - Google Patents
Verfahren zur Bestimmung von Proteinen und PolypeptidenInfo
- Publication number
- DE1598945C3 DE1598945C3 DE1598945A DE1598945A DE1598945C3 DE 1598945 C3 DE1598945 C3 DE 1598945C3 DE 1598945 A DE1598945 A DE 1598945A DE 1598945 A DE1598945 A DE 1598945A DE 1598945 C3 DE1598945 C3 DE 1598945C3
- Authority
- DE
- Germany
- Prior art keywords
- antibodies
- labeled
- protein
- bound
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004169 proteins and genes Human genes 0.000 title claims description 49
- 108090000623 proteins and genes Proteins 0.000 title claims description 49
- 238000000034 method Methods 0.000 title claims description 36
- 102000004196 processed proteins & peptides Human genes 0.000 title claims description 28
- 108090000765 processed proteins & peptides Proteins 0.000 title claims description 28
- 229920001184 polypeptide Polymers 0.000 title claims description 27
- 239000002245 particle Substances 0.000 claims description 29
- 229940088597 hormone Drugs 0.000 claims description 20
- 239000005556 hormone Substances 0.000 claims description 20
- 230000002285 radioactive effect Effects 0.000 claims description 9
- 238000011088 calibration curve Methods 0.000 claims description 4
- 239000007790 solid phase Substances 0.000 claims description 4
- 229920003176 water-insoluble polymer Polymers 0.000 claims description 4
- 230000009137 competitive binding Effects 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 23
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 102000036639 antigens Human genes 0.000 description 15
- 108091007433 antigens Proteins 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 239000000427 antigen Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 102000006771 Gonadotropins Human genes 0.000 description 11
- 108010086677 Gonadotropins Proteins 0.000 description 11
- 239000012482 calibration solution Substances 0.000 description 11
- 239000002622 gonadotropin Substances 0.000 description 11
- 229920005654 Sephadex Polymers 0.000 description 10
- 239000012507 Sephadex™ Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 238000010586 diagram Methods 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- 229940125396 insulin Drugs 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 210000002381 plasma Anatomy 0.000 description 8
- 229920002307 Dextran Polymers 0.000 description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 7
- 239000000122 growth hormone Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 102000018997 Growth Hormone Human genes 0.000 description 6
- 108010051696 Growth Hormone Proteins 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- 235000011130 ammonium sulphate Nutrition 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 241000700198 Cavia Species 0.000 description 4
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000001588 bifunctional effect Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108010005991 Pork Regular Insulin Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- -1 e.g. B. I 125 Chemical compound 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229940094892 gonadotropins Drugs 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- FPIGOBKNDYAZTP-UHFFFAOYSA-N 1,2-epoxy-3-(4-nitrophenoxy)propane Chemical compound C1=CC([N+](=O)[O-])=CC=C1OCC1OC1 FPIGOBKNDYAZTP-UHFFFAOYSA-N 0.000 description 1
- OLKYVRJEDDPVFH-UHFFFAOYSA-N 3-[3-hydroxy-3-(4-nitrophenoxy)propoxy]-1-(4-nitrophenoxy)propan-1-ol Chemical group C=1C=C([N+]([O-])=O)C=CC=1OC(O)CCOCCC(O)OC1=CC=C([N+]([O-])=O)C=C1 OLKYVRJEDDPVFH-UHFFFAOYSA-N 0.000 description 1
- 241000605059 Bacteroidetes Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
- 229960000874 thyrotropin Drugs 0.000 description 1
- 230000001748 thyrotropin Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Fluid-Damping Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7541/66A SE343949B (Direct) | 1966-06-02 | 1966-06-02 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE1598945A1 DE1598945A1 (de) | 1971-04-01 |
| DE1598945B2 DE1598945B2 (de) | 1976-06-24 |
| DE1598945C3 true DE1598945C3 (de) | 1980-10-02 |
Family
ID=20271656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1598945A Expired DE1598945C3 (de) | 1966-06-02 | 1967-06-01 | Verfahren zur Bestimmung von Proteinen und Polypeptiden |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3555143A (Direct) |
| AT (1) | AT283590B (Direct) |
| BE (1) | BE699352A (Direct) |
| CH (1) | CH484426A (Direct) |
| CS (1) | CS159223B2 (Direct) |
| DE (1) | DE1598945C3 (Direct) |
| DK (1) | DK123795B (Direct) |
| ES (1) | ES341257A1 (Direct) |
| FI (1) | FI48508C (Direct) |
| GB (1) | GB1192784A (Direct) |
| NL (1) | NL158937B (Direct) |
| NO (1) | NO126594B (Direct) |
| SE (1) | SE343949B (Direct) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE29480E (en) * | 1966-10-21 | 1977-11-22 | Pharmacia Ab | Method for determining vitamin B12 and reagent therefor |
| USRE28442E (en) * | 1968-01-19 | 1975-06-03 | Radioimmunoassay of angiotensin and rehin activity | |
| USRE31006E (en) * | 1968-09-24 | 1982-08-03 | Akzona Incorporated | Process for the demonstration and determination of reaction components having specific binding affinity for each other |
| US3940475A (en) * | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| ZA72151B (en) * | 1971-02-01 | 1972-09-27 | Hoffmann La Roche | Immunological diagnostic reagent |
| US3853987A (en) * | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3896218A (en) * | 1972-07-13 | 1975-07-22 | Research Corp | Radiommunoassay determining the hepatitis associated antigen content of blood |
| DE2322533C2 (de) * | 1972-11-06 | 1986-08-28 | Pharmacia AB, Uppsala | Verfahren zum Binden von Immunoglobulin und Hilfsmittel zur Durchführung des Verfahrens |
| US3897212A (en) * | 1973-01-30 | 1975-07-29 | Albert Einstein Medical Center | Test for systemic lupus erythematosus |
| US3867518A (en) * | 1973-03-09 | 1975-02-18 | Hoffmann La Roche | Radioimmunoassay for insulin |
| US3896217A (en) * | 1973-03-19 | 1975-07-22 | Summa Corp | Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent |
| US3854041A (en) * | 1973-04-24 | 1974-12-10 | J Waters | Process for detection of biological activity |
| US4039652A (en) * | 1973-10-11 | 1977-08-02 | Miles Laboratories, Inc. | Column method of immunoassay employing an immobilized binding partner |
| US3997525A (en) * | 1974-01-16 | 1976-12-14 | Bio-Tec, Inc. | Tetra-125 iodo-di-tyramine of digitalis derivative and process for making the same |
| US4041146A (en) * | 1975-05-01 | 1977-08-09 | General Electric Company | Method for detection of biological particles |
| US4034072A (en) * | 1975-07-21 | 1977-07-05 | Corning Glass Works | Serum hepatitis test |
| USRE32696E (en) * | 1975-09-04 | 1988-06-14 | Akzona Incorporated | Enzymatic immunological method for determination of antigens and antibodies |
| US4020151A (en) * | 1976-02-17 | 1977-04-26 | International Diagnostic Technology, Inc. | Method for quantitation of antigens or antibodies on a solid surface |
| US4081245A (en) * | 1976-05-03 | 1978-03-28 | Beckman Instruments, Inc. | Immunoassay procedure employing novel immunochemical composites |
| US4081246A (en) * | 1976-05-03 | 1978-03-28 | Beckman Instruments, Inc. | Solid phase column immunoassay procedure employing novel immunochemical composites |
| US4081244A (en) * | 1976-05-03 | 1978-03-28 | Beckman Instruments, Inc. | Immunoassay procedure employing novel immunochemical composites |
| US4108974A (en) * | 1976-08-27 | 1978-08-22 | Bio-Rad Laboratories, Inc. | Radioimmunoassay for thyroid hormone |
| US4102979A (en) * | 1976-09-22 | 1978-07-25 | Hoffmann-La Roche Inc. | Radioimmunoassay for benzoylecgonine |
| US4090850A (en) * | 1976-11-01 | 1978-05-23 | E. R. Squibb & Sons, Inc. | Apparatus for use in radioimmunoassays |
| US4071522A (en) * | 1977-01-06 | 1978-01-31 | Hoffmann-La Roche Inc. | Tritiated O-benzoylecgonine |
| DE2824917A1 (de) | 1977-07-13 | 1979-02-01 | Corning Glass Works | Biologisch aktive konjugate |
| US4256629A (en) * | 1978-02-06 | 1981-03-17 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
| US4170454A (en) * | 1978-03-30 | 1979-10-09 | Union Carbide Corporation | Process for the preparation of a solid-phase radioimmunoassay support and use thereof |
| DE2816841A1 (de) * | 1978-04-18 | 1979-10-31 | Max Planck Gesellschaft | Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii) |
| FR2437398A1 (fr) * | 1978-06-20 | 1980-04-25 | Commissariat Energie Atomique | Compose iode utilisable comme traceur en radio-immunologie |
| US4292403A (en) * | 1978-08-24 | 1981-09-29 | Akzona Incorporated | Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins |
| US4244940A (en) * | 1978-09-05 | 1981-01-13 | Bio-Rad Laboratories, Inc. | Single-incubation two-site immunoassay |
| US4289747A (en) * | 1978-12-26 | 1981-09-15 | E-Y Laboratories, Inc. | Immunological determination using lectin |
| US4297337A (en) * | 1979-04-13 | 1981-10-27 | Corning Glass Works | Solid-phase immunoassays using magnetic glass |
| US4289748A (en) * | 1979-05-31 | 1981-09-15 | United States Of America | Ultrasensitive enzymatic radioimmunoassay method |
| US4254096A (en) * | 1979-10-04 | 1981-03-03 | Bio-Rad Laboratories, Inc. | Reagent combination for solid phase immunofluorescent assay |
| US4522922A (en) * | 1982-04-16 | 1985-06-11 | Jose Carro | Soluble assay |
| US4628037A (en) * | 1983-05-12 | 1986-12-09 | Advanced Magnetics, Inc. | Binding assays employing magnetic particles |
| US4677058A (en) * | 1983-05-19 | 1987-06-30 | Karl Tryggvason | Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme |
| US4808528A (en) * | 1983-05-19 | 1989-02-28 | Karl Tryggvason | Antibody composition for the detection of malignant cells with metastatic cell activity |
| US4713347A (en) * | 1985-01-14 | 1987-12-15 | Sensor Diagnostics, Inc. | Measurement of ligand/anti-ligand interactions using bulk conductance |
| US5219554A (en) * | 1986-07-03 | 1993-06-15 | Advanced Magnetics, Inc. | Hydrated biodegradable superparamagnetic metal oxides |
| US5069216A (en) * | 1986-07-03 | 1991-12-03 | Advanced Magnetics Inc. | Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastrointestinal tract |
| US7615368B1 (en) | 1994-06-17 | 2009-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Microarrays of polypeptides |
| US5856194A (en) * | 1996-09-19 | 1999-01-05 | Abbott Laboratories | Method for determination of item of interest in a sample |
| US5795784A (en) * | 1996-09-19 | 1998-08-18 | Abbott Laboratories | Method of performing a process for determining an item of interest in a sample |
| US6670115B1 (en) * | 1999-11-24 | 2003-12-30 | Biotronic Technologies, Inc. | Devices and methods for detecting analytes using electrosensor having capture reagent |
| EP1377827A2 (en) * | 2001-04-10 | 2004-01-07 | NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen in Reutlingen Stiftung Bürgerlichen Rechts | Method for determining analyte molecules in a sample |
| FR2833487B1 (fr) * | 2001-12-18 | 2004-08-27 | Oreal | Compositions cosmetiques comprenant des polymeres a fonctions chimiques complementaires |
| FR2833485B1 (fr) * | 2001-12-18 | 2005-02-11 | Oreal | Composition cosmetique formant un gainage mou comprenant un polymere a squelette non silicone et a fonctions reactives |
| US20110143378A1 (en) * | 2009-11-12 | 2011-06-16 | CyVek LLC. | Microfluidic method and apparatus for high performance biological assays |
| US9500645B2 (en) | 2009-11-23 | 2016-11-22 | Cyvek, Inc. | Micro-tube particles for microfluidic assays and methods of manufacture |
| US9651568B2 (en) | 2009-11-23 | 2017-05-16 | Cyvek, Inc. | Methods and systems for epi-fluorescent monitoring and scanning for microfluidic assays |
| US9700889B2 (en) | 2009-11-23 | 2017-07-11 | Cyvek, Inc. | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results |
| ES2649559T3 (es) | 2009-11-23 | 2018-01-12 | Cyvek, Inc. | Método y aparato para realizar ensayos |
| US9759718B2 (en) | 2009-11-23 | 2017-09-12 | Cyvek, Inc. | PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use |
| US9855735B2 (en) | 2009-11-23 | 2018-01-02 | Cyvek, Inc. | Portable microfluidic assay devices and methods of manufacture and use |
| US10065403B2 (en) | 2009-11-23 | 2018-09-04 | Cyvek, Inc. | Microfluidic assay assemblies and methods of manufacture |
| CN106552682B (zh) | 2011-03-22 | 2020-06-19 | 西维克公司 | 微流体装置以及制造方法和用途 |
| KR102114734B1 (ko) | 2012-03-08 | 2020-05-25 | 싸이벡, 아이엔씨 | 미세유체 분석 장치용 마이크로튜브 입자 및 제조방법 |
| FR3035799B1 (fr) | 2015-05-06 | 2017-05-05 | Elicityl | Support pour la purification de liquides biologiques |
| FR3035794B1 (fr) | 2015-05-06 | 2017-05-05 | Elicityl | Procede pour la purification du sang total ou d'un produit issu du sang |
| US10228367B2 (en) | 2015-12-01 | 2019-03-12 | ProteinSimple | Segmented multi-use automated assay cartridge |
-
1966
- 1966-06-02 SE SE7541/66A patent/SE343949B/xx unknown
-
1967
- 1967-05-30 DK DK281267AA patent/DK123795B/da unknown
- 1967-05-30 NL NL6707479.A patent/NL158937B/xx not_active IP Right Cessation
- 1967-06-01 NO NO168.427A patent/NO126594B/no unknown
- 1967-06-01 CH CH776367A patent/CH484426A/fr not_active IP Right Cessation
- 1967-06-01 ES ES341257A patent/ES341257A1/es not_active Expired
- 1967-06-01 BE BE699352D patent/BE699352A/xx not_active IP Right Cessation
- 1967-06-01 DE DE1598945A patent/DE1598945C3/de not_active Expired
- 1967-06-01 GB GB25309/67A patent/GB1192784A/en not_active Expired
- 1967-06-02 CS CS404367A patent/CS159223B2/cs unknown
- 1967-06-02 FI FI671568A patent/FI48508C/fi active
- 1967-06-02 US US643190A patent/US3555143A/en not_active Expired - Lifetime
- 1967-06-02 AT AT516667A patent/AT283590B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI48508C (fi) | 1974-10-10 |
| ES341257A1 (es) | 1968-10-01 |
| NO126594B (Direct) | 1973-02-26 |
| US3555143A (en) | 1971-01-12 |
| CH484426A (fr) | 1970-01-15 |
| AT283590B (de) | 1970-08-10 |
| GB1192784A (en) | 1970-05-20 |
| CS159223B2 (Direct) | 1974-12-27 |
| FI48508B (Direct) | 1974-07-01 |
| NL158937B (nl) | 1978-12-15 |
| DK123795B (da) | 1972-07-31 |
| SE343949B (Direct) | 1972-03-20 |
| BE699352A (Direct) | 1967-12-01 |
| DE1598945B2 (de) | 1976-06-24 |
| DE1598945A1 (de) | 1971-04-01 |
| NL6707479A (Direct) | 1967-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1598945C3 (de) | Verfahren zur Bestimmung von Proteinen und Polypeptiden | |
| DE2806146C2 (de) | Tumor-spezifisches Glykoprotein und dessen Verwendung zur Krebsdiagnose beim Menschen | |
| DE3205849C2 (de) | Reagens zur immunologischen Bestimmung | |
| DE2816841A1 (de) | Radioimmunologische bestimmung von prokollagen (typ iii) und prokollagen- peptid (typ iii) | |
| EP0013930B1 (de) | Immunogen, Antikörper für ein Thymus-Hormon, markiertes Thymus-Hormon und Verfahren zur Bestimmung dieses Thymushormons | |
| DE2734118A1 (de) | Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen | |
| DE1768512B2 (de) | Verfahren zur herstellung von in wasser unloeslichen, chemisch oder biologisch wirksamen derivaten von biopolymeren | |
| DE19524572A1 (de) | Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind | |
| DE2653032A1 (de) | Radioimmun-nachweisverfahren fuer ein schilddruesenhormon und dafuer geeignetes reagens | |
| DE2608667A1 (de) | Diagnostisches feststoffreagens und verfahren zu dessen herstellung | |
| CH627187A5 (Direct) | ||
| EP0001223A2 (de) | Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz. | |
| DE3879085T2 (de) | Snrnp-a-antigen und fragmente davon. | |
| USRE29474E (en) | Method for the determination of proteins and polypeptides | |
| DE2021968A1 (de) | Verfahren zur Blutuntersuchung unter Verwendung radioaktiver Indikator-Substanzen und Ionenaustauscherharz-Membranen | |
| DE1767899A1 (de) | Verfahren zur Isolierung von Antigenen und Antikoerpern | |
| EP0001812A1 (de) | Verfahren zur Herstellung gereinigten Alpha-1-Fetoproteins und dessen Verwendung | |
| DE3888437T2 (de) | Immobilisierte Antikörper. | |
| DE2714751C2 (Direct) | ||
| CH645727A5 (de) | Praeparat zur bestimmung von menschlichem beta-2-mikroglobulin, verfahren zu seiner herstellung und seine verwendung. | |
| DE1673015B1 (de) | Verfahren zur radiochemischen bestimmung von vitamin b tief 12 | |
| DE2126128A1 (de) | Medizinisches Testverfahren, Reagens und Additiv zur Durchführung des Verfahrens | |
| DE2733561C3 (de) | Spezifisches Reagens für den Immuntest für Thymopoietin | |
| DE2539258C3 (de) | Radioimmunologisches Analyseverfahren zur Bestimmung des Gesamt-Thyroxins in einer Serumprobe | |
| DE2062558A1 (de) | Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) |